Patents by Inventor Matthew Arnold

Matthew Arnold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11538055
    Abstract: An open loop cashless payment system incents a consumer account holder to transact in a physical store with a merchant who agrees to make an auditable donation to a charity when the transaction is conducted on an account issued to the consumer account holder. The consumer account holder may direct the donation to a specific charity within a predetermined geographically determined community where the transaction was physically conducted. The consumer account holder can register an obligation to make a donation matching that of the merchant, where the consumer account holder's donation is initially paid by the consumer account's issuer for reimbursement by the consumer account holder to the issuer after the consumer account holder receives their account statement. The merchant's acquirer, the issuer, and a transaction handler for the issuer and acquirer may also make donations as directed by the consumer account holder.
    Type: Grant
    Filed: June 14, 2013
    Date of Patent: December 27, 2022
    Assignee: EDATANETWORKS INC.
    Inventors: Terrance Patrick Tietzen, Matthew Arnold Macpherson Bates
  • Publication number: 20220405776
    Abstract: Links are generated between local merchants and community programs for merchant incentives to customers for the programs which are tracked for online-offline customer transactions using incentives. Participants' identifiers are linked to payment sources. Offline-online transaction data is collected in a data storage area. All data in the data storage area may be utilized by logic tool, which may provide information, such as details of consumer behavior and analytic reporting. Rich data provided by pre-transaction chat sessions between merchants and potential customers are matched with rich data provided by subsequent transactions between the merchants and their customers, and a level of certainty may be determined as to the accuracy of the match of a prior chat session to a subsequent transaction.
    Type: Application
    Filed: June 15, 2022
    Publication date: December 22, 2022
    Inventors: Terrance Patrick TIETZEN, Matthew Arnold MacPherson BATES
  • Publication number: 20220391940
    Abstract: Methods, devices and media for a pre-enrollment registration system are described.
    Type: Application
    Filed: June 21, 2022
    Publication date: December 8, 2022
    Inventors: Terrance Patrick TIETZEN, Matthew Arnold Macpherson BATES
  • Publication number: 20220391939
    Abstract: Methods, systems and device for verifying a transaction in a loyalty or advertising system are described. One such method includes: receiving, at least one processor, transaction data associated with a transaction between a customer and a merchant; determining, at the at least one processor, from the transaction data whether the customer and the merchant are associated with the loyalty or advertising system; and upon determining from the transaction data whether the transaction corresponds to a reward or advertisement, triggering the redemption of the reward or advertisement.
    Type: Application
    Filed: May 18, 2022
    Publication date: December 8, 2022
    Inventors: Terrance Patrick TIETZEN, Matthew Arnold Macpherson BATES, Ronald Rog
  • Patent number: 11501114
    Abstract: The generating of actionable recommendations for tuning model metrics of an Artificial Intelligence (AI) system includes partitioning a key performance indicator (KPI) range associated with a target system into a plurality of buckets. Log data including at least one KPI of the target system and one or more AI model metrics is partitioned and distributed across the plurality of buckets. For each bucket, an aggregate value of the one or more AI model metrics across the log data is computed and weighted according to the volume of log data in that bucket. A correlation factor between the aggregate value and a representative KPI value for each bucket is determined. A model tuning recommendation to increase ranking of the AI model metrics according to the determined correlation factor is provided to an output device and/or to the AI system for updating the one or more AI model.
    Type: Grant
    Filed: December 2, 2019
    Date of Patent: November 15, 2022
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Matthew Arnold, Evelyn Duesterwald, Darrell Reimer, Michael Desmond, Harold Leon Ossher, Robert Yates
  • Patent number: 11492351
    Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds of Formula (I) to pharmaceutical compositions comprising compounds of Formula (I) and to methods of use thereof, such as methods of treating cancer using the compounds of Formula (I) and pharmaceutical compositions comprising those compounds.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: November 8, 2022
    Assignee: Mirati Therapeutics, Inc.
    Inventors: Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson, Svitlana Kulyk, Jon Kuehler, Anthony Ivetac
  • Patent number: 11485738
    Abstract: The present invention relates to compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    Type: Grant
    Filed: January 29, 2019
    Date of Patent: November 1, 2022
    Assignee: MIRATI THERAPEUTICS, INC.
    Inventors: Matthew Arnold Marx, Matthew Randolph Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen, John Michael Ketcham
  • Patent number: 11479551
    Abstract: The present invention relates to compounds that inhibit Protein Arginine N-Methyl Transferase 5 (PRMT5) activity. In particular, the present invention relates to compounds of Formula (I) to pharmaceutical compositions comprising compounds of Formula (I) and to methods of use thereof, such as methods of treating cancer using the compounds of Formula (I) and pharmaceutical compositions comprising those compounds.
    Type: Grant
    Filed: September 11, 2020
    Date of Patent: October 25, 2022
    Assignee: Mirati Therapeutics, Inc.
    Inventors: Thomas P. Bobinski, Christopher Ronald Smith, Matthew Arnold Marx, John Michael Ketcham, Aaron Craig Burns, John David Lawson, Svitlana Kulyk, Jon Kuehler, Anthony Ivetac
  • Patent number: 11453683
    Abstract: Compounds that inhibit KRas G12D; in particular, compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor, and in particular, methods of treating cancer. The compounds have a general structure represented by Formula (I): or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 27, 2020
    Date of Patent: September 27, 2022
    Assignees: MIRATI THERAPEUTICS, INC., ARRAY BIOPHARMA INC.
    Inventors: Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson, Matthew Arnold Marx, Christopher Ronald Smith, Shelley Allen, James F. Blake, Mark Joseph Chicarelli, Joshua Ryan Dahlke, Donghua Dai, Jay Bradford Fell, John Peter Fischer, Macedonio J. Mejia, Brad Newhouse, Phong Nguyen, Jacob Matthew O'Leary, Spencer Pajk, Martha E. Rodriguez, Pavel Savechenkov, Tony P. Tang, Guy P. A. Vigers, Qian Zhao, Dean Russell Kahn, John Gaudino, Michael Christopher Hilton
  • Publication number: 20220274990
    Abstract: Disclosed are compounds that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, disclosed are compounds of Formula (I) and pharmaceutical compositions thereof, and methods of using the compounds and pharmaceutical compositions in, for example, methods of treating cancer.
    Type: Application
    Filed: June 3, 2020
    Publication date: September 1, 2022
    Inventors: Matthew Arnold MARX, John Michael KETCHAM, Aaron Craig BURNS
  • Patent number: 11403659
    Abstract: Methods, devices and media for a pre-enrollment registration system are described.
    Type: Grant
    Filed: December 17, 2020
    Date of Patent: August 2, 2022
    Assignee: EDATANETWORKS INC.
    Inventors: Terrance Patrick Tietzen, Matthew Arnold Macpherson Bates
  • Publication number: 20220213097
    Abstract: Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.
    Type: Application
    Filed: April 21, 2020
    Publication date: July 7, 2022
    Inventors: John Michael KETCHAM, Aaron Craig BURNS, Matthew Arnold MARX
  • Patent number: 11379718
    Abstract: Methods, systems and computer program products for improving ground truth quality for modeling are provided. Aspects include receiving a plurality of data inputs, wherein each of the plurality of data inputs has an associated label. Aspects also include training a model based on the plurality of data inputs. Aspects also include generating a plurality of vector representations corresponding to the plurality of data inputs based on the model. Aspects also include clustering the plurality of vector representations into one or more clusters. Aspects also include identifying at least one anomalous data input based on the one or more clusters. The at least one anomalous data input can be a data input of the plurality of data inputs that is mislabeled, contributes to an ambiguous class structure or is an outlier. Aspects also include outputting a notification that provides an indication of the at least one anomalous data input.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: July 5, 2022
    Assignee: INTERNATIONAL BUSINESS MACHINES CORPORATION
    Inventors: Michael Desmond, Matthew Arnold, Jeffrey Scott Boston
  • Publication number: 20220194961
    Abstract: The present invention relates to compounds that inhibit at least one of KRas wild type, KRas G12A, KRas G12C, KRas G12D, KRas G12R, KRas G12S, KRas G12V, KRas G13D and KRas Q61H, pharmaceutical compositions comprising the compounds and methods of use therefor.
    Type: Application
    Filed: December 16, 2021
    Publication date: June 23, 2022
    Inventors: Xiaolun Wang, Anthony Ivetac, Svitlana Kulyk, John David Lawson, Matthew Arnold Marx, Christopher Ronald Smith
  • Publication number: 20220198528
    Abstract: A donor incentivizes a payer to make a real time payment to a payee, as facilitated by operation of one RTPS Technology, by terms set by the donor to make an auditable donation to an affinity entity designated by the payer. To incent such real time payments within a predetermined geographic location, the donor's terms may limit its donation by a derivation of navigation time between the payer and payee, and/or by date and time of the real time payment from the payer to the payee. The payer can direct the donation by the donor to one of more affinity entities within the payer's own geographic community, and/or within a community where the real time payment was physically conducted. An payer can also make a donation to the affinity entity at the time of real time payment by the payer where the donation by the payer is paid by a payer financial institution that issued a payer account of the payer.
    Type: Application
    Filed: March 5, 2022
    Publication date: June 23, 2022
    Applicant: edatanetworks, Inc.
    Inventors: Terrance Patrick TIETZEN, Matthew Arnold Macpherson BATES
  • Patent number: 11367097
    Abstract: Methods, systems and device for verifying a transaction in a loyalty or advertising system are described. One such method includes: receiving, at least one processor, transaction data associated with a transaction between a customer and a merchant; determining, at the at least one processor, from the transaction data whether the customer and the merchant are associated with the loyalty or advertising system; and upon determining from the transaction data whether the transaction corresponds to a reward or advertisement, triggering the redemption of the reward or advertisement.
    Type: Grant
    Filed: November 2, 2020
    Date of Patent: June 21, 2022
    Inventors: Terrance Patrick Tietzen, Matthew Arnold Macpherson Bates, Ronald Rog
  • Patent number: 11267812
    Abstract: The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
    Type: Grant
    Filed: May 17, 2017
    Date of Patent: March 8, 2022
    Assignees: MIRATI THERAPEUTICS, INC., ARRAY BIOPHARMA INC.
    Inventors: John P. Fischer, Jay Bradford Fell, James F. Blake, Ronald Jay Hinklin, Macedonio J. Mejia, Erik James Hicken, Mark Joseph Chicarelli, John J. Gaudino, Guy P. A. Vigers, Laurence E. Burgess, Matthew Arnold Marx, James Gail Christensen, Matthew Randolph Lee, Pavel Savechenkov, Henry J. Zecca, Tony P. Tang
  • Publication number: 20220012774
    Abstract: Systems, data access management utilities, and methods generate links between local merchants and community programs, whereby the merchant may provide incentives to customers in relation to community programs. The implementations may track community programs, as well as online and offline customer transactions with merchants that make use of the incentive. Implementations may include as participants, customers, merchants, community organizations, intermediaries, and other groups or individuals. Participants may have participant identifiers, which may be linked to a payment source. Data may be collected about all participants, either expressly, or from offline or online transactions between merchants and customers utilizing a participant identifier, and the data may be stored in a data storage area.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 13, 2022
    Inventors: Terrance Patrick TIETZEN, Matthew Arnold Macpherson BATES
  • Patent number: 11220509
    Abstract: The present disclosure relates to compounds of Formula (I), or pharmaceutically, acceptable salts thereof, that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present disclosure relates to compounds, or pharmaceutically acceptable salts thereof pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds of Formula (I), or pharmaceutically acceptable salts thereof, and pharmaceutical compositions comprising compounds of Formula (I), or pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: January 11, 2022
    Assignee: MIRATI THERAPEUTICS, INC.
    Inventors: Matthew Arnold Marx, Matthew Randolph Lee, Thomas P. Bobinski, Aaron Craig Burns, Nidhi Arora, James Gail Christensen, John Michael Ketcham
  • Publication number: 20210380570
    Abstract: The present invention relates to compounds that inhibit KRas G12C. In particular, the present invention relates to compounds that irreversibly inhibit the activity of KRas G12C, pharmaceutical compositions comprising the compounds and methods of use therefor.
    Type: Application
    Filed: May 6, 2019
    Publication date: December 9, 2021
    Inventors: Matthew Arnold Marx, Matthew Randolph Lee, James F. Blake, Mark Joseph Chicarelli, Jay Bradford Fell, John P. Fischer, Erik James Hicken, Pavel Savechenkov, Tony Tang, Guy P.A. Vigers, Henry J. Zecca